Research group
Micael Widerström lab researches healthcare-associated infections caused by multidrug-resistant staphylococci.
Antibiotic resistance is recognized by the WHO as one of the greatest threats to global health. A particular challenge is infections associated with implanted medical devices such as hip and knee prostheses. In Sweden, more than 30,000 such operations are performed each year.
While highly successful from a medical perspective, these implants can be complicated by infections that are extremely difficult to treat. This is largely because the bacteria form biofilms – protective layers that shield them from both the immune system and antibiotics. As a result, patients may suffer from long-term pain, disability, and repeated surgeries, leading to reduced quality of life and significant healthcare costs. Multidrug-resistant staphylococci are a common cause of these infections.
Research areas:
Transmission pathways in the hospital environment, in collaboration with the Statens Serum Institut in Copenhagen. (Cooperation with Anders Johansson lab)
Translational studies of biofilms, analyzing bacterial gene expression in prosthetic joint infections to identify new therapeutic targets. (Cooperation with Kemal Avican lab och Johan Normark lab).
Development and evaluation of diagnostic methods for prosthetic joint infections.
One Health perspectives, including a recently published project with the Swedish National Veterinary Institute (SVA) investigating resistance and virulence in coagulase-negative staphylococci from bovine mastitis, with attention to zoonotic aspects.
Financing:
The research is financed by Centrala ALF, Visare Norr, Formas, and Kempestiftelserna.
Head of research
Micael WiderströmAssociate professor, senior consultant (attending) physician